BENIGN TUMORS

advertisement
BENIGN TUMORS
I.
EPIDERMAL
A. Keratosis
1. Actinic--sun induced, premalignant ill-defined pink keratotic plaques in sun
exposed distribution.
2. Seborrheic--flesh colored to brown waxy verrucous plaques. Well defined
lesions, global distribution. No malignant potential. Sign of Leser-Trelat.
B. Keratoacanthoma--sun induced. "Self-healing" squamous cell carcinoma.
Extremely rapidly growing indurated keratotic pink nodule with central crater and
keratin core.
C. Skin Tag--acrochordon, fibroepithelial polyp. Flexural folds. ?Associated with
GI polyps.
D. Clavus--"corn". Thick localized callus with keratin plug.
E. Verrucae--warts. Human papilloma virus, 60 known subtypes.
1. Flat
2. Plantar
3. Vulgaris
4. Filiform
5. Venereal--condyloma acuminata
F. Cutaneous Horn--indurated pink papule with keratin horn. Wart, actinic
keratosis, r/o squamous cell carcinoma
G. Nevus Sebaceus of Jadassohn
II.
DERMAL
A. Dermatofibroma--firm, pink-brown plaque or nodule. + "dimple" sign. Lower
leg distribution, female greater than male.
B. Hemangioma
1. Capillary
2. Cavernous
3. Cherry angioma
C. Pyogenic Granuloma--rapidly growing hemangioma with "collarette", Friable,
purulent surface.
D. Lipoma--moveable firm rubbery subcutaneous nodule(s) with distinct capsule.
Isolated or numerous. Often familial.
E. Epidermal Inclusion Cyst--"sebaceous" cyst, "wen".
III. PIGMENTED
A. Nevus
1. Dermal
2. Junctional
3. Compound
4. Congenital
5. Blue
6. Dysplastic--over 5 mm. Macular. Irregular notched borders. Variegated
pigment from pink to brown, eccentrically.
7. Halo
B. Lentigo--tan maculae, "liver" spots.
1. simplex
2. actinic
C. Ephelid--freckle
Rovner
MALIGNANT TUMORS
Basal Cell Carcinoma--sun induced. Minimal metastatic potential
I.
A. Nodular--pearly, telangiectatic borders. "Rodent" ulcer.
B. Superficial--eroded, scaling pink plaques.
II.
Squamous Cell Carcinoma
A. Sun-induced--little metastatic potential.
Often arise from existing actinic
keratosis. Indurated pink scaling plaques.
B. Mucosal--dangerous with high metastatic potential.
C. in situ--Bowen's Disease.
Well defined psoriasiform plaque in sun exposed
area(s).
III. Melanoma
A. Types
1. Superficial Spreading
2. Nodular
3. Lentigo maligna (Hutchinson's freckle)
(i)
Lentigo maligna melanoma
4. Acro-lentiginous
B. Prognosis
1. Type
2. Location ("BANS" areas)
3. Depth
a
Clark's level
b
Breslow scale:
Depth
%Survival (5 yr)
0--.75 mm
98-100%
.75--1.5 mm
90--95%
1.5--3.0 mm
50--75%
over 3.0 mm
less than 50%
C. Treatment
1. wide local excision
2. ?lymph node dissection - [sentinel lymph node]
3. chemotherapy
4. immune modulation
Rovner
INFLAMMATORY DISORDERS
I.
ECZEMA--Dermatitis
Acute--"juicy" red ill defined plaques with or without vesiculation; pruritus
Chronic-lichenification--scaling thickened pink plaques with increased skin
markings; pruritus
A. Contact--unusual configuration and distribution limited to areas of contact
1. Allergic-a
specific sensitivity, not dose dependent
b
eg: poison ivy, Nickel, fragrances,
c
preservatives, Neomycin
2. Irritant--non specific
a
dose dependent
b
eg: soaps, lye
B. Seborrheic--"dandruff"
1. scalp, central face, chest ("oily" areas)
2. ill defined, greasy, yellow scaling pink plaques
3. Pityrosporum ovale
C. Dyshidrotic--"Pompholyx"
1. palms, soles
2. "tapioca" vesicles
D. Stasis--shins - edema, with diffuse erythema, scaling and purpura
E. Xerotic--"dry" skin
F. Atopic--asthma
1. flexural fold involvement
2. food allergies (milk, eggs, nuts, wheat, citrus)--RAST testing
3. familial
4. cataracts
G. Treatment: identification and avoidance of offending agent(s)--patch test
1. steroids-topical and systemic
2. antihistamines
3. moisturizers
4. antibiotics (Staph aureus)
II.
PSORIASIS
3% of American population
Etiology unknown--increased cell turnover
Polygenic inheritance
A. Vulgaris
1. well defined pink plaques with "micaceous" scales
2. distribution
a
elbows, knees
b
gluteal cleft
c
scalp
d
nails--pitting, oil staining
e
sites of trauma--"Koebner phenomenon"
B. Pustular
1. sterile pustules, lakes of pus with diffuse erythematous background
2. palms and soles most frequent sites
3. eruptive (von Zumbusch)--generalized involvement, often steroid induced
C. Guttate
1. Wide spread, small "raindrop spattered" plaques
2. post Strep, viral infections
D. Psoriatic arthritis--occurs in 3-5% of psoriasis patients
1. mono-articular--most common
2. mutilans (distal interphalangeal, "pencil in cup")--pathognomonic
E. Treatment:
1. topical steroids
2. tar
3. UVB
4. PUVA
5. Methotrexate
6. Retinoids
7. vitamin D
8. cyclosporine
III. LICHEN PLANUS
A. Flat topped violaceous polygonal plaques with white lacy striae (Wickham's)
B. ankles, wrists
C. oral (buccal mucosa)
D. nails (pterygium)
E. extreme pruritus
Rovner
REACTIVE ERYTHEMAS
Urticaria, Angioedema Type I hypersensitivity
I.
Red wheals, plaques with central translucency; pruritic!
Lesions recur in crops and waves, each lasting under 24 hours
Acute--under 6 weeks
Chronic--over 6 weeks
A. Types:
1. Angio[neurotic]edema--swelling of lips, genitalia, eyelids
2. Contact--rare; DMSO, cinnamates
3. Papular--insect bite reaction
4. Dermographism
5. Hereditary Angioedema--complement mediated
B. Etiology
1. Drugs--antibiotics (PCN, sulfa) salicylates
2. Foods--shellfish, tartrazine dyes
3. Physical Factors--heat, cold, pressure
4. Stress
C. Treatment--antihistamines
1. Steroids
2. epinephrine
II.
Erythema Multiforme
Symmetric target "Iris" lesions, often involving palms, soles
Resolving within days to weeks
A. Etiology
1. Infectious--Herpes virus, mycoplasma, deep fungi
2. Drugs-- -phenobarbital, PCN, sulfa
B. Treatment--self limited
1. ? steroids
2. antihistamines
3. treat underlying condition
C. Variants
1. Steven's Johnson Syndrome
a
Erythema multiforme with bullous, erosive lesions
b
Mucosal involvement
c
Severe, potentially life threatening
2. Toxic Epidermal Necrolysis
a
Widespread denudation, sloughing of inflamed skin
b
Mortality--over 50%!
III. Erythema Nodosum (panniculitis)
A. painful subcutaneous nodules on anterior shins, bilaterally
B. bruising with pink/yellow/purple shiny plaques or nodules
C. NO ulceration
D. Etiology: Infectious (viral, Strep, deep fungi)
E. Drugs (BCP's, PCN)
F. Inflammatory Bowel Disease
G. Sarcoid
H. Treatment--self limited, lasting up to several weeks
1. NSAID's
2. steroids
IV.
Drug Reactions--Type IV hypersensitivity (except urticaria)
A. Morbilliform--symmetric, pruritic coalescent pink papules and plaques
1. typically begins within 1 week of new drug
2. Bactrim, PCN
B. Urticaria
C. "Fixed"--phenolphthalein (Ex-Lax); Tetracyclines
D. Phototoxic--Tetracyclines, Thorazine, NSAID's
E. Alopecia--heparin, coumadin
F. Bullous--griseofulvin, nalidixic acid
G. Lupus Erythematosus--hydralazine, procainamide, INH
H. Psoriasis--lithium
Rovner
INFECTIOUS DISEASES OF THE SKIN
Viral
I.
A. Herpes simplex (types I and II)
1. Primary
2. Recurrent
B. Zoster--reactivated Varicella
C. Molluscum Contagiosum
D. Human Papilloma Virus
1. Warts
2. Condyloma acuminata
3. Cervical dysplasia
4. Laryngeal polyps
E. Exanthems
1. nonspecific--similar to morbilliform drug reaction
2. specific
II.
a
Fifth Disease--Parvovirus
b
Sixth Disease (Roseola)--HSV VI
c
Hand, foot and mouth disease--Coxsackie virus
d
?Pityriasis Rosea - ?HSV VII
Bacterial
A. Impetigo
1. Staph aureus, NOT Strep
2. Honey colored crusts, erosions with a red base
3. May be bullous
4. Treatment:
a
Systemic antibiotics
b
Topical antibiotics ineffective except Bactroban!
B. Cellulitis
1. Staph, Strep, H. influenza (children)
2. Tender, bright red dermal plaques with indistinct borders
3. Constitutional symptoms--fever, arthralgias, malaise
C. Erysipelas
1. Strep usually causative
2. Extremely well demarcated red indurated plaques
3. Recurrence is frequent
D. Mycobacteria
1. Leprosy--M. leprae
Tuberculoid
TT
Borderline
BT BB
2. Atypical Mycobacterium-a
M. marinum
b
Fish tank (swimming pool) granuloma
E. Pseudomonas--hot tub folliculitis
Lepromatous
BL LL
F. Disseminated
1. Gonococcemia
a
rare, painful hemorrhagic pustules
b
palms and soles
c
septic arthritis
2. Meningococcemia
a
gun metal grey hemorrhagic pustules
b
EXTREMELY DANGEROUS
3. Rickettsia--Rocky Mountain Spotted Fever
a
wood tick vector
b
acral hemorrhagic papules
III. Fungal
A. Superficial
1. Dermatophytes
a
"ringworm, athlete's foot, jock itch"
b
annular scaling pink plaques with central clearing
c
Skin--Tinea corporis, cruris, pedis, etc.
d
Hair--Tinea capitis
e
Nail--Tinea unguium
f
3 genera
i
Trichophyton spp
ii
Epidermophyton
iii
Microsporum spp
g
Diagnosis--KOH slide
h
Treatment
i
topical--imidazoles
ii
systemic--griseofulvin, ketoconazole
2. Candida--C. albicans
a
bright red plaques with satellite pustules
b
skin:
moist intertriginous areas (groin, glans, angles of mouth)
c
oral:
thrush
d
Treatment:
nystatin, imidazoles (NOT griseofulvin)
3. Pityrosporum
a
P orbiculare, ovale
b
normal commensal in oily areas
c
Tinea Versicolor (Malassezia furfur)
d
Folliculitis
B. Deep
1. Begin as self limited acute respiratory infection with fever, cough with
eventual spread to skin (in rare instances)
2. Histoplasmosis
a
oral lesions
b
Ohio River basin
c
Erythema multiform, Erythema nodosum
3. Blastomycosis
a
Eastern USA
b
vegetative, verrucous plaques
4. Coccidioidomycosis
a
Pacific Southwest
b
EM, EN
5. Paracoccidioidomycosis--Amazon basin
6. Sporotrichosis--verrucous papules, nodules, plaques, peat moss, rose thorns
IV.
Infestations
A. Scabies--Sarcoptus scabii
B. Pediculosis
1. capitus--head lice
2. corporis--body lice (organisms found in seams of clothes only, not on body)
3. pubis
a
pubic lice "crabs"
b
also may affect eyelashes
Parasites
V.
A. Cutanea larva migrans (creeping eruption)
B. Schistosomiasis--(duck itch, swimmer's itch)
VI.
Spirochetes
A. Syphilis--Treponema pallidum
1. a. Primary--chancre:
negative
painless, indurated ulcer at inoculation site, RPR
2. Secondary--Pityriasis rosea like rash 1 to 6 months after 10 infection
a
brown macules on palms and soles
b
mucous patches
c
Condyloma lata
d
RPR positive; spirochetes recoverable from all lesions
e
latent--RPR remains positive; no lesions
3. Tertiary--5 to 30 years after latency
a
gumma
b
arthritides
c
cardiac, neurologic involvement
B. Lyme Disease
1. Borrelia burgdorferii
2. deer tick vector
3. triphasic course:
a
10--Erythema chronicum migrans
b
20--Fever, arthritis
c
30--Late sequelae (cardiac, neurologic)
Rovner
GENODERMATOSES
Ichthyoses
I.
1.
Genetically determined conditions with thick scaling plates
2.
Two mechanisms:
a
Increased cohesiveness (I. vulgaris, X-Linked Ich).
b
Increased cellular production (lamellar Ich., epidermolytic hyperkeratosis)
3.
Infants often present with membrane ("colloidian baby")
4.
Symptoms:
5.
II.
a
pruritus
b
cosmesis
c
bacterial 20 infections
d
odor
e
ectropion
f
fluid, electrolyte imbalance
Treatment:
a
antibiotics
b
moisturization (LacHydrin)
Neurofibromatosis (von Recklinghausen's)
A. Autosomal dominant
B. cafe-au-lait macules (at least 6 greater than 1 cm.)
C. neurofibromas
1. typical
2. plexiform-may eventuate in neurosarcoma
D. pheochromocytoma
E. acoustic neuroma
F. **Crowe's sign--axillary freckling
G. **Lisch nodules
III. Tuberous Sclerosis
A. Autosomal dominant
B. Ash leaf macules
C. Adenoma sebaceum (angiofibromas)
D. **Shagreen patch
E. mental retardation
IV.
Peutz Jaegher's
A. Autosomal dominant
B. Multiple lentigines
C. Small intestinal polyps (pre adenocarcinomatous)
Gardiner's
V.
A. Autosomal dominant
B. multiple cysts
C. colonic polyps (premalignant)
VI.
Osler-Weber-Rendu
A. Autosomal dominant
B. Familial hemorrhagic telangiectasia
C. Telangiectases on lips, oral mucosa, skin
D. Bleeding from CNS, GI tract
Rovner
BULLOUS DISORDERS
Epidermolysis Bullosa--noninflammatory inheritable blistering disorders,skin
I.
fragility
A. E.B. Simplex
B. E.B. Letalis (junctional)
C. E.E. Dystrophica
D. Treatment:
trauma avoidance
1. cool environs
2. antibiotics, local wound care
3. steroids
4. Dilantin
II.
Pemphigus
A. Superficial
1. P. foliaceous
2. P. erythematosus
B. Deep
1. P. vulgaris
2. P. vegetans
C. flaccid bullae on uninflamed base
D. + Nikolsky sign
E. Pathogenesis: autoantibodies to intercellular cement
F. Histopathology
1. acantholysis
2. intrerepidermal bullae
3. + immunofluorescence intracellularly in epidermis
G. Treatment:
1.
Steroids!
2. immunosuppressants
III. Bullous Pemphigoid
A. Tense bullae on inflamed base
B. Nikolsky sign
C. Pathogenesis: autoantibodies to basement membrane zone protein
D. Histopathology
1. no acantholysis
2. intact epidermis overlying bulla with eo's, PMN's
3. + immunofluorescence at DE junction
E. Treatment:
IV.
Steroids, immunosuppressants
Dermatitis Herpetiformis
1. Intensely pruritic papulovesicles over elbows, knees, buttocks
2. gluten enteropathy (asymptomatic)
3. Pathogenesis: IgA antibodies in dermal papillae
4. Histopathology: Necrosis of dermal papillae with PMN's
5. Treatment: Dapsone, gluten free diet, antihistamines
V.
Porphyria Cutanea Tarda
A. Blisters on dorsal hands with sun exposure
B. Zygomatic hypertrichosis
C. Marked skin fragility
D. Pathogenesis:
1. defect in uroporphyrinogen decarboxylase
2. increased porphyrins excreted in urine (positive fluorescence)
E. Aggravated by BCP's, EtOH
F. Treatment:
1. phlebotomy
2. antimalarials
3. EtOH avoidance
4. sunscreens
Rovner
COLLAGEN VASCULAR DISORDERS
I.
Lupus erythematosis
A. Discoid LE (DLE)
1. pink, violaceous well defined plaques in sun exposed distribution
2. scarring, including alopecia
3. follicular plugging, atrophy
4. ANA-negative
5. no systemic manifestations
6. Treatment:
a
steroids (systemic, topical)
b
antimalarials
c
sunscreens
B. Systemic LE (SLE)
1. autoimmune antibody/antigen complex deposition with Type III inflammation
2. drug induced
a
hydralazine
b
procainamide
c
isoniazid INH
3. 4 or more ARA criteria for diagnosis:
a
malar ("butterfly") rash with sun exposure
b
discoid lesions
c
photosensitivity
d
oral ulcers
e
arthritis
f
serositis (pleuritis, pericarditis)
g
renal disease
h
neurologic sx's (seizures, neuropathy, psychosis)
i
hematologic (anemia, pancytopenia)
j
immunologic (anti-DNA ab's; LE prep; false + RPR) ANA
4. Treatment:
a
steroids
b
immunosuppressants
c
antimalarials
d
sunscreens
C. Subacute LE (SCLE)
1. ANA negative lupus
2. +SSA, SSB antibodies (anti Ro, anti La)
3. less cardiac, renal involvement compared to SLE
4. small, annular red plaques in sun exposed areas
5. Neonatal lupus:
a
(infants born to mothers with SCLE)
b
30 heart block
c
discoid lesions
d
anemia, "HELP" syndrome (Hepatic Enzymes Low Platelets)
e
II.
usually resolves within 6 months, but heart block permanent
Dermatomyositis
A. Inflammatory disorder of proximal muscles, skin
B. Associated with internal malignancy 25 to 50% in patients over 55
C. Skin:
1. "heliotrope" rash
2. Gottron's papules
3. periungual telangiectases
D. Muscle: limb/girdle weakness with abnormal EMG findings
E. Laboratory:
1. elevated CPK, Aldolase
2. + ANA
3. ESR elevation
F. Treatment
1. treat underlying malignancy
2. steroids
III. Scleroderma
A. Morphea (localized)
1. atrophic plaques without systemic involvement
B. CREST Syndrome
1. Calcinosis cutis
2. Raynaud's disease
3. Esophageal strictures
4. Sclerodactyly
5. Telangiectases
C. PSS (Progressive Systemic Sclerosis)
1. proximal sclerosis
2. pulmonary fibrosis
3. renal disease
4. cardiac (restrictive cardiomyopathy)
D. Treatment:
1. steroids
2. d-penicillamine
Rovner
VASCULITIS
Definition:
Inflammation with necrosis of blood vessels resulting in variable clinical
presentations depending upon:
1. size of vessel
2. type of vessel
3. histological infiltrate
Pathophysiology:
Antigen-Antibody Complex Formation

Immune Complex Deposition

Complement Derived Chemotaxis

PMN Lysosomal Enzyme Release

Vessel Wall Injury, Necrosis

VASCULITIS
I.
Vasculitis - Types
A. Hypersensitivity Group (Leukocytoclastic)
1. Vessel type: small, usually post capillary venules
2. Symptoms: Skin-Palpable Purpura
a
vesicles, bullae, ulceration
b
urticaria (collagen vascular disease)
3. Systemic:
a
Joints--arthritis (50%)
b
Renal--hematuria
c
Other--GI tract
4. Etiology:
a
Infectious (Strep, viral, Rickettsial)
b
Drug Reaction
c
Collagen vascular disease
d
Cryoglobulinemia
e
Internal Malignancy
f
Henoch-Schonlein Purpura
g
i
Palpable purpura (dependent areas-legs and buttocks)
ii
Abdominal pain
iii
Arthritis
iv
Hematuria
v
Increased IgA
Idiopathic
5. Laboratory work-up
a
CBC, Platelets
b
Urinalysis, BUN, Creatinine
c
Chest x-ray
d
ANA
e
Cryoglobulins
f
Serum Protein Electropheresis
g
ESR (nonspecific)
6. Differential Diagnosis:
a
Thrombocytopenia
b
Sepsis
7. Treatment
a
removal of offending agent
b
steroids
c
dapsone
B. Polyarteritis Group (Periarteritis)
1. Polyarteritis Nodosa
a
Vasculitis of small-medium sized arteries with segmental (skip)
involvement.
b
Symptoms:
i
Constitutional
ii
Renal--hypertension, glomerulonephritis
iii
Neuromuscular--arthritis,
myalgia,
sensorimotor
neuropathy
(mononeuritis multiplex)
iv
Gastrointestinal--functional
v
Cutaneous--Livedo reticularis, Nodules (painful shiny red nodules
in crops usually on lower extremities), Ulcerations
vi
Other--cardiac, CNS
c
Laboratory Work-Up: Nonspecific
d
Treatment:
i
Steroids (50% 5 yr. survival)
ii
Cyclophosphamide (80% 5 yr. survival)
iii
None (10% 50 year survival)
2. Churg-Strauss
a
Allergic granulomatous angiitis
b
Asthma, Eosinophilia
c
Pulmonary vessel involvement--100%
d
Splenic involvement--70%
C. Granulomatous
1. Wegener's Granulomatosis
a
Granulomatous vasculitis of upper and lower respiratory tract,
glomerulonephritis, and other small arteries
b
c
d
Symptoms:
i
Respiratory Tract--100%
ii
sinusitis, rhinitis, septal destruction, cough, dyspnea
iii
Renal--80% glomerulonephritis
iv
Cutaneous--40-50% nodules, ulcers
v
Other--joints, CNS, cardiac
Laboratory work-up
i
ESR markedly elevated
ii
Chest x-ray (cavitary lesions, nodules)
Treatment:
i
90% 2 yr. mortality without treatment
ii
cyclophosphamide and steroids
2. Giant Cell Arteritis
II.
a
Temporal Arteritis (Polymyalgia Rheumatica)
b
Giant cell infiltrate of large arteries (temporal, carotid)
c
Severe, disabling musculoskeletal pain,
d
Blindness without immediate steroids in high doses
e
ESR extremely elevated (over 100)
SYSTEMIC DISEASE
A. Pruritus
1. Thyroid (hyper- or hypo)
TSH, T4
2. Renal disease
BUN, Creatinine
3. Hepatic disease
LFT's
4. Malignancy (Hodgkins Disease)
Chest x-ray
5. Polycythemia vera
CBC, platelets
6. Diabetes
glucose
B. Endocrine
1. Adrenal
a
b
Addison's Disease
i
Hypoadrenalism
ii
generalized bronzing
iii
dark pigmentation on gums
Cushing's
i
Hyperadrenalism
ii
moon facies
iii
buffalo hump
iv
hirsutism
v
acanthosis nigracans
2. Thyroid
a
hyperthyroidism--pretibial myxedema, thyroid acropachy
b
hypothyroidism--myxedema, alopecia, xerosis, macroglossia
3. Diabetes Mellitis
a
Necrobiosis Lipoidica Diabeticorum
b
Diabetic Dermopathy
C. Malignancy
1. Pruritus
2. Dermatomyositis
3. Acanthosis Nigracans
4. Acquired Ichthyosis
5. malignant down - lanugo hairs
D. AIDS
1. Oral hairy leukoplakia--EB virus
2. Kaposi's Sarcoma
3. Sudden, severe Seborrheic Dermatitis
4. Molluscum contagiosum-- refractory
5. Unusual or opportunistic infections
6. Bacillary angiomatosis
7. Chronic cutaneous herpes virus infections
8. Lipodystrophy
Rovner
DISEASES OF SKIN APPENDAGES
I.
Pilo-sebaceous unit
A. Acne: inflammatory papules, cysts, or nodules due to follicular plugging and
anaerobic breakdown of trapped sebum due to Propionbacterium acnes.
1. Types:
a
A. vulgaris
b
A. cosmetica
c
A. fulminans
d
A. conglobata
e
Chloracne--dioxin induced (Agent Orange)
2. Treatment:
a
avoidance of comedogenic materials
b
Retin-A (tretinoic acid)
c
Benzoyl peroxide
d
Antibiotics:
i
tetracyclines
ii
erythromycins (topical or systemic)
iii
amoxicillin, Bactrim
iv
clindamycin (Cleocin-T), usually topical
e
Accutane (isotretinoic acid)
f
Diet and acne cleansers have NO therapeutic effect
II.
Sweat ducts
A. Eccrine--Miliaria
1. Miliaria rubra--"prickly heat" perifollicular papules
2. Miliaria crystallina--crystal clear superficial vesicles, febrile
3. Miliaria profunda--hyperthermia, no skin signs
B. Apocrine
1. Hidradenitis suppurativa--cysts, nodules, sinus tracts and scarring in axillary,
inguinal areas
III. Alopecia
A. Scarring--DLE, lichen planus, male pattern
B. Non scarring
1. Alopecia areata--stress induced; pernicious anemia, thyroid disease
2. Telogen effluvium--post partum, stress, crash diets, febrile illness, drugs
3. Anagen effluvium--chemotherapy, trichotillomania
IV.
Nails
A. Tinea unguium
B. Psoriasis
C. 1/2 and 1/2 nails--renal disease
D. White nails (Terry's nails)--liver disease
E. Nail Tic Deformity
V.
Pigmentation
A. Melasma, chloasma--reticular hyperpigmentation in sun exposed areas of face,
more common in females, estrogen induced
B. Vitiligo
1. Autoimmune--may be associated with thyroid anti-microsomal antibodies and
pernicious anemia; symmetric depigmentation, accentuated by Wood's light
exam; etiology unknown, may run in families
Treatment: psoralens, UVB or UVA, topical steroids
2. Contact: phenols (photographic developers)
Surgery of the Skin
CRYOTHERAPY: minus 40˚ Centigrade for 30 seconds with LN2
wart, keratoses
not suitable for tissue requiring histopathologic exam
ELECTROCAUTERY:
Electrodesiccation
Electrofulguration
Electrocauterization
Hemostasis
Superficial lesions, except warts; telangiectases
CURETTAGE;
wart, keratoses
Basal Cell Carcinoma--E&C Electrodesiccation and curettage
SCALPEL SURGERY;
"cold steel" surgery
Elliptical excision --3 times the width of lesion
Anesthesia-- 1% xylocaine w/ or w/o epinephrine
Benadryl injectable
Saline
Closure
primary--subcuticular sutures for hemostasis and
tension placement
Secondary--packing
Granulation
Flaps and grafts--large wounds, cosmesis, function
LASER SURGERY; argon--vascular tumors
CO2--warts, condyloma
Neodymium: YAG
Tunable dyes--vascular, pigmented, and other solid tumors
MOH'S (CHEMO) SURGERY:
SKIN BIOPSY:
punch
shave
recurrent malignant tumors
Affords potential best cosmetic result
Rovner
TOPICAL DERMATOLOGIC THERAPY
IV.
VEHICLES (BASES)
A. POWDERS
1. reduce friction; absorb moisture
2. eg. talc, cornstarch, Zeasorb
B. SHAKE LOTIONS/EMULSIONS
1. suspension of non-soluble in liquid/oil
2. drying, soothing
3. eg. Calamine
C. SOLUTIONS
1. active medication dissolved in aqueous or alcohol solution
2. useful in hair bearing areas
D. GELS
1. similar to a solution, but with an added polymer to provide substance - less
"runny" than solutions
E. CREAMS
1. oil-in-water (light) or water-in-oil (heavy)
2. require preservatives, emulsifiers, stabilizers
3. cosmetically acceptable
F. OINTMENTS
1. nonaqueous base, usually petrolatum
2. greasy, cosmetically not desirable, especially in hair bearing areas
3. usually best delivery system in terms of effectiveness
G. PASTES
1. nonvanishing, thick wax based, remain on skin
2. cosmetically unacceptable, messy
SOAKS, BATHS
V.
A. soothing anti-inflammatory, antipruritic, may be anti- infective or used to dry
oozing areas or loosen debris in wounds
B. Examples:
1. colloidal oatmeal (Aveeno) - soothing
2. Aluminum Subacetate (Dome Boro's) - drying. antibacterial
3. Daikon's Solution - saline with sodium hypochlorite - good debriding agent
4. Tar - anti-inflammatory, useful for eczema, psoriasis
5. Oil - soothing, hydrating
VI.
ANTI- INFLAMMATORY
A. TOPICAL STEROIDS
1. Potency (as determined by vasocontrictor assay):
a
Classification: Class I - super potent - Class VII - least potent
b
Concentration
c
Vehicle
d
Substitution (fluorination, esterification)
2. Usage
a
Type of skin
b
Area to be covered - 30 gms per total body application
c
Location to be treated - facial and intertrigenous areas require special
attention
d
Cost - generic vs. Brand-name
B. TAR PREPARATIONS
1. May be compounded with steroids
2. Messy, staining, potentially irritating
a
LCD (Liquor Carbonis Detergens)
b
Anthralin - synthetic
c
Pine Tar Extracts
C. SPECIAL CASES
1. Viaform
a
Useful in intertrigenous areas
2. Topical Antihistamines and Anesthetics
a
Any preparation ending with "-dryl"
or "-caine" (eg. Benedryl,
Caladryl, Benzocaine) is potentially sensitizing. Zonalon (topical
doxepin) may be effective
3. Capsaicin
a
Depletes substance P
VII. TOPICAL ANTIBIOTICS
A. ANTI-INFECTIVES
1. Bacitracin, Polymixin B, Neomycin - wound healing, - prophylaxis only
Polysporin , Neosporin
NB: Products with neomycin (eg. "triple" antibiotic) should be avoided due to
high incidence of hypersensitivity!
2. Mupiricin (Bactroban) - effective for impetigo
3. Cleocin, Erythromycin - folliculitis
4. Sulfonamides (Azulfidine) - burns
5. Cleansing Agents
a
Soaps - Deodrant (Triclosan)
b
Scrubs
i chlorhexidene (Hibiclens)
ii povidone/iodine (Betadine)
iii
hexachlorophene (PhisoHex)
c
Alcohol
d
Hydrogen Peroxide
B. ACNE
1. Erythromycin
2. Clindamycin
3. Tetracycline
4. Meclocycline
5. Sulfonamides
6. Metronidazole (Flagyl) - rosacea
VIII.
TOPICAL ANTI FUNGALS
A. Candida, yeast
1. nystatin (Mycostat)
B. Fungi
1. Powders
a
useful in prevention
i
tolnaftate
ii
micostatin
iii
undecylenic acid
2. Shampoos
a
Zinc - (Head & Shoulders)
b
Tar - (T-Gel)
c
Selenium Sulfide - Selsun Blue
d
Nizoral
3. Creams/Lotions
a
Imidazoles
i
clotrimazole (Lotrimin)
ii
Ketoconazole, econazole, miconazole
b
Cyclopirox (Loprox)
c
Allyl Amines (Lamisil)
Rovner
SYSTEMIC DERMATOLOGIC THERAPY
IX.
ANTIBIOTICS - Widespread, deep or potentially life threatening infection, (eg.
folliculitis, cellulitis, ecthyma)
A. Anti-Staphylococcal
1. Erythromycin
2. Beta-lactamase resistant Penicillins (Dicloxacillin, Augmentin)
3. Cephalosporins (Keflex, Duricef)
4. Penicillin and Tefracycline are NOT appropriate.
B. Anti-Streptococcal
1. Erythromycin
2. Penicillins
C. Acne
1. Tetracyclines, Minocycline, Doxycyclene
2. Erythromycins
3. Amoxicillin
4. Trimethoprim/sulfa (Bactrim)
5. Clindamycin
6. Cephalosporins (Duricef)
X.
ANTI-FUNGALS - Widespread or deep infections; nail infections
A. Griseofulvin
1. eg. Gris Peg, Fulvicin
2. Dermatophyte infections only - no yeasts!
3. Potentially hepatotoxic, phototoxic
B. Imidazoles
1. eg. Ketoconazole (Nizoral), Itraconazole (Sporanox)
2. Drug interactions
3. Potential hepatotoxicity
C. Allyl Amines - (Lamisil)
XI.
ANTI-HISTAMINES
A. Sedating
1. Hydroxyzine (Atarax)
2. Diphenhidramine (Benadryl)
3. Cyproheptadine (Periaction)
B. Non-sedating
1. Terfenadine (Seldane) Interaction with Macrolides
2. Astemizole (Hismanal)
and imidazoles
3. Loratadine (Claritin)
C. Mildly sedating
1. Cetirizine (Zyrtec)
XII. STEROIDS - used to control acute flare of eczema, pemphigus,urticaria, and
other inflammatory dermatoses except psoriasis
A. Prednisone - usual dose is 0.5 to 1 mg/kg tapering over 3 to 4 weeks
B. Other - equivalence:
Decadron Triamicinolone, Prednisone Hydrocortisone Methyl Prednisdone
Prednisolone
0.75mg
4mg
5mg
20mg
May be given PO, IM, IV, or intralesionally
XIII.
RETINOIDS - teratogenic
A. Accutane (isotretinoin)
B. Tegison (etretinate)
C. Arotonoids
Rovner
PEDIATRIC DERMATOLOGY
I.
CLASSIC EXANTHEMS
A. First Disease (MEASLES, Rubeola)
1. Etiology: myxovirus
2. Clinical: age of onset after 6-12 months, 10-11 days' incubation, then fever,
coryza, rash
3. Enanthem: Koplik's spots - 1-2 days prior to onset of rash
4. Exanthem: morbilliform
a
eruption 14 days after inoculation
b
Posterior scalp-- neck-- face-- trunk, upper extremities
c
2-3 days' duration
5. Sequelae: neurologic in up to 50%
6. Prevention:
a
live attenuated vaccine (MMR) after 12 months
b
earlier killed vaccines led to atypical measles
B. Second Disease (SCARLET FEVER)
1. Etiology: erythrotoxin from Group A Beta-hemolytic Strep, usually from
pharygeal infection ("Strep" Throat)
2. Clinical: Sudden, severe after 2-4 days' incubation with fever, sore throat,
headache
3. Exanthem:
a
oropharyngeal erythema
b
"Strawberry" tongue
4. Sequelae:
a
rheumatic fever 2-3 weeks post infection
b
glomerulonephritis
5. Treatment: Penicillin
C. Third Disease (RUBELLA, German Measles)
1. Etiology: paramyxovirus
2. Clinical:
a
12-25 days' incubation
b
4-5 day prodrome (fever, malaise) with adenopathy (post cervical)
3. Exanthem:
a
2-3 day course
b
small pink papules on face with peripheral spread to trunk and arms over 1
day
c
clearing in upper extremity, with involvement of lower extremity
4. Enanthem:
a
Forchheimer's spots - petechiae on soft palate
b
coincident with exanthem
5. Sequelae:
a
Usually none
b
Neonatal Rubella Syndrome
6. Prevention: live attenuated virus (MMR)
D. Fourth Disease (Duke's Disease)
1. Historical significance only
2. ? ECHO virus exanthem
3. ? Scarlatiniform eruption
E. Fifth Disease (Erythema Infectiosum)
1. Etiology: Human Parvovirus
2. Clinical:
a
children 5-15 years
b
mild constitutional symptoms
c
1-2 week duration, waxing and waning
3. Exanthem:
a
"slapped" cheek appearance
b
reticulated erythema over upper back, shoulders, buttocks
4. Enanthem: none
5. Sequelae: none, but adults may have lingering malaise, arthragias, fever
F. Sixth Disease (Exanthem Subitum, Roseola)
1. Etiology: Herpes Virus VI
2. Clinical:
a
young children (6 months to 2 years)
b
10-12 days' incubation
c
High fever spike, 2-3 days' duration
3. Exanthem:
a
abruptly follows defervescence
b
short lived (1 day's duration)
c
faint pink macules from neck to trunk
d
facial sparing
4. Enanthem: none
5. Sequelae: febrile seizures, (non specific)
6. Prevention: none
II.
VARICELLA (CHICKEN POX)
A. Etiology: Varicella Zoster Virus
B. Clinical:
1. 10-20 days' incubation
2. 1 day prodrome of fever, malaise
C. Exanthem:
1. successive crops
2. congested papules becoming vesicular ("dew drop on a rose petal"), then
crusted
3. central distribution (face, scalp, trunk) palms, soles spared
4. 1 week's duration (maybe up to 3 weeks)
D. Enanthem: flaccid vesicles progress to white ulceration on hard palate, tonsillar
pillars
E. Sequelae:
1. uncommon in immunocompetent
2. Zoster (Shingles)
F. Treatment: Acyclovir, Valcyclovir, Famcyclovir
G. Prevention: Vaccine
III. KAWASAKI'S DISEASE (mucocutaneous lymph node syndrome)
A. Etiology: uncertain
B. Clinical: infants, young children
C. Criteria:
1. 5 or more days of fever
2. conjunctivitis
3. Strawberry tongue, oropharyngeal erythema
4. erythema and subsequent peeling of hands, feet
5. scarlatiniform rash
6. acute cervical adenopathy
7. elevated platelets
D. Sequelae: coronary arteritis, aneurysms
E. Treatment:
1. ? Antibiotics
2. ? Steroids
IV.
COMMON CHILDHOOD PROBLEMS - (treatment considerations)
A. Atopic Dermatitis
B. Warts
C. Molluscum Contagiosum
D. Poison Ivy
E. Ringworm
F. Drug eruptions
G. Viral Exanthems
H. Acne
I. Impetigo
NEONATAL DERMATOLOGY
"TORCH" SYNDROME - "blueberry muffin baby"
I.
A. Toxoplasmosis
B. Other
C. Rubella
D. Cytomegalovirus
E. Herpes Simplex
II.
COMMON NEONATAL ERUPTIONS
A. Erythema Toxicum [Neonatorum]
B. Neonatal Acne
C. Milia
Download